Reduction in labile plasma iron during treatment with deferasirox, a once-daily oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia

This subgroup analysis evaluated the effect of once-daily oral deferasirox on labile plasma iron (LPI) levels in patients from the prospective, 1-yr, multicentre ESCALATOR study. Mean baseline liver iron concentration and median serum ferritin levels were 28.6 ± 10.3 mg Fe/g dry weight and 6334 ng/m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Daar, Shahina, Pathare, Anil, Nick, Hanspeter, Kriemler-Krahn, Ulrike, Hmissi, Abdel, Habr, Dany, Taher, Ali
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2009
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2730549/
https://ncbi.nlm.nih.gov/pubmed/19191863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1600-0609.2008.01204.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados